BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36209348)

  • 1. Assessment of the beliefs, needs, and expectations for genetic counseling of patients with hypermobile Ehlers-Danlos syndrome.
    Ahimaz P; Kramer T; Swaroop P; Mitchell M; Hernan R; Anyane-Yeboa K; Pereira EM
    Am J Med Genet A; 2022 Nov; 188(11):3172-3183. PubMed ID: 36209348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
    Estrella E; Frazier PA
    Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
    Thwaites PA; Gibson PR; Burgell RE
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
    Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
    Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
    [No Abstract]   [Full Text] [Related]  

  • 8. Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.
    McGillis L; Mittal N; Santa Mina D; So J; Soowamber M; Weinrib A; Soever L; Rozenberg D; Liu L; Tse Y; Katz J; Charames GS; Murphy K; Vadas P; Slepian MP; Walsh S; Wilson L; Adler A; Franzese A; Hussey L; Nevay DL; Guzman J; Clarke H
    Am J Med Genet A; 2020 Mar; 182(3):484-492. PubMed ID: 31840928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.
    Mu W; Muriello M; Clemens JL; Wang Y; Smith CH; Tran PT; Rowe PC; Francomano CA; Kline AD; Bodurtha J
    Am J Med Genet A; 2019 Apr; 179(4):561-569. PubMed ID: 30703284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice.
    Feldman ECH; Homan KJ; Williams SE; Ting TV; Goldschneider KR; Kashikar-Zuck S
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):121. PubMed ID: 37845704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypermobile Ehlers-Danlos syndrome patients on the workflow and professional satisfaction of genetic counselors.
    Eckstein L; Helm BM; Baud R; Francomano CA; Halverson C
    J Genet Couns; 2023 Nov; ():. PubMed ID: 37984420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
    Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
    Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
    Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
    Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary chronic pain management strategies in patients with Ehlers-Danlos syndromes.
    Gullapalli PA; Javed S
    Pain Manag; 2023 Jan; 13(1):5-14. PubMed ID: 36305215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.